|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| (11) | Number of the document | 2435432 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10721246.6 |
| Date of filing the European patent application | 2010-05-26 | |
| (97) | Date of publication of the European application | 2012-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-24 |
| (46) | Date of publication of the claims translation | 2015-09-25 |
| (86) | Number | PCT/US2010/036198 |
| Date | 2010-05-26 |
| (87) | Number | WO 2010/138588 |
| Date | 2010-12-02 |
| (30) | Number | Date | Country code |
| 181203 P | 2009-05-26 | US |
| (72) |
BRUNCKO, Milan, US
DING, Hong, US
DOHERTY, George, US
ELMORE, Steven, US
HASVOLD, Lisa, US
HEXAMER, Laura, US
KUNZER, Aaron R., US
SONG, Xiaohong, US
SOUERS, Andrew J., US
SULLIVAN, Gerard, US
TAO, Zhi-Fu, US
WANG, Gary T., US
WANG, Le, US
WANG, Xilu, US
WENDT, Michael, US
MANTEI, Robert, US
HANSEN, Todd M., US
|
| (73) |
AbbVie Ireland Unlimited Company,
c/o Conyers Corporate Services (Bermuda) Limited, Clarendon House, 2 Church Street, Hamilton HM11,
BM
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Apoptozę sukeliantys agentai, skirti vėžio ir imuninių ir autoimuninių ligų gydymui |
| APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES |
| Payment date | Validity (years) | Amount | |
| 2026-04-10 | 17 | 347.00 EUR |
| 2027-05-26 |